Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Quote

Not a forecast

“Thus, the rush on the part of Lily and Novo to get all these remarkable trials done that prove their effectiveness in other indications— beyond weight loss—so that Medicare can cover them.”
· Happy $2,000/annual Out-Of-Pocket Cap For Medicare Beneficiaries Day · substack post

Because Medicare Part D does not cover weight-loss drugs, the author describes Eli Lilly and Novo Nordisk rushing to complete trials of GLP-1s in other indications so that Medicare can cover them.

Descriptive, retrospective, or a statement of preference; no future state asserted.